Migdal Insurance & Financial Holdings Ltd. Takes $154,000 Position in DaVita HealthCare Partners Inc. (DVA)

Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of DaVita HealthCare Partners Inc. (NYSE:DVA) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,600 shares of the company’s stock, valued at approximately $154,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Pzena Investment Management LLC increased its holdings in DaVita HealthCare Partners by 2.1% during the 2nd quarter. Pzena Investment Management LLC now owns 3,398 shares of the company’s stock worth $220,000 after purchasing an additional 71 shares in the last quarter. Eqis Capital Management Inc. increased its holdings in DaVita HealthCare Partners by 2.2% during the 2nd quarter. Eqis Capital Management Inc. now owns 4,600 shares of the company’s stock worth $298,000 after purchasing an additional 100 shares in the last quarter. Thrivent Financial For Lutherans increased its holdings in DaVita HealthCare Partners by 4.4% during the 1st quarter. Thrivent Financial For Lutherans now owns 5,730 shares of the company’s stock worth $389,000 after purchasing an additional 240 shares in the last quarter. Founders Capital Management LLC increased its holdings in DaVita HealthCare Partners by 0.6% during the 2nd quarter. Founders Capital Management LLC now owns 93,824 shares of the company’s stock worth $6,076,000 after purchasing an additional 520 shares in the last quarter. Finally, Speece Thorson Capital Group Inc. boosted its stake in shares of DaVita HealthCare Partners by 0.5% in the 2nd quarter. Speece Thorson Capital Group Inc. now owns 280,515 shares of the company’s stock worth $18,166,000 after buying an additional 1,360 shares during the last quarter. 84.73% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Transcript Daily and is owned by of Transcript Daily. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at https://transcriptdaily.com/2017/11/13/migdal-insurance-financial-holdings-ltd-takes-154000-position-in-davita-healthcare-partners-inc-dva.html.

DVA has been the topic of a number of research analyst reports. TheStreet downgraded DaVita HealthCare Partners from a “b” rating to a “c+” rating in a research note on Wednesday, August 2nd. Zacks Investment Research upgraded DaVita HealthCare Partners from a “sell” rating to a “hold” rating in a research note on Thursday, August 3rd. Jefferies Group LLC restated a “hold” rating and issued a $70.00 target price on shares of DaVita HealthCare Partners in a research note on Thursday, August 3rd. Royal Bank Of Canada restated a “hold” rating and issued a $64.00 target price on shares of DaVita HealthCare Partners in a research note on Wednesday, September 6th. Finally, KeyCorp restated a “hold” rating on shares of DaVita HealthCare Partners in a research note on Tuesday, October 10th. Four investment analysts have rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of C$63.00.

DaVita HealthCare Partners Inc. (NYSE DVA) traded down C$0.11 during trading on Monday, hitting C$55.00. 1,805,600 shares of the stock traded hands, compared to its average volume of 1,588,182. The company has a market capitalization of $10,407.74, a PE ratio of 15.71, a P/E/G ratio of 11.05 and a beta of 0.98. DaVita HealthCare Partners Inc. has a 52-week low of C$52.51 and a 52-week high of C$70.16. The company has a current ratio of 1.40, a quick ratio of 1.35 and a debt-to-equity ratio of 1.79.

DaVita HealthCare Partners (NYSE:DVA) last released its quarterly earnings results on Tuesday, November 7th. The company reported C$0.81 earnings per share for the quarter, missing the consensus estimate of C$0.94 by C($0.13). The firm had revenue of C$3.92 billion during the quarter, compared to the consensus estimate of C$3.91 billion. DaVita HealthCare Partners had a return on equity of 13.31% and a net margin of 3.40%. The company’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.95 EPS. equities research analysts forecast that DaVita HealthCare Partners Inc. will post 3.43 EPS for the current year.

DaVita HealthCare Partners declared that its board has approved a share buyback plan on Tuesday, October 10th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply